Vise Technologies Inc. Acquires New Position in Acadia Healthcare Company, Inc. $ACHC

Vise Technologies Inc. bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the 2nd quarter, HoldingsChannel.com reports. The fund bought 19,739 shares of the company’s stock, valued at approximately $583,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC grew its stake in shares of Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares in the last quarter. Wells Fargo & Company MN raised its stake in shares of Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after acquiring an additional 1,510 shares in the last quarter. Global Retirement Partners LLC purchased a new position in Acadia Healthcare in the second quarter valued at $68,000. Caitong International Asset Management Co. Ltd grew its stake in Acadia Healthcare by 4,264.8% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after purchasing an additional 5,203 shares in the last quarter. Finally, Parallel Advisors LLC grew its stake in Acadia Healthcare by 857.8% during the 1st quarter. Parallel Advisors LLC now owns 6,858 shares of the company’s stock worth $160,000 after purchasing an additional 6,142 shares in the last quarter.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on ACHC shares. Raymond James Financial raised Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price target on the stock in a research report on Monday, May 4th. UBS Group boosted their price target on shares of Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 9th. Jefferies Financial Group raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $24.50 to $30.00 in a research report on Wednesday, June 3rd. Barclays boosted their target price on shares of Acadia Healthcare from $25.00 to $32.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 30th. Finally, KeyCorp lifted their price target on Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a report on Tuesday, July 14th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Acadia Healthcare has a consensus rating of “Hold” and a consensus target price of $29.85.

Acadia Healthcare Trading Up 3.2%

Shares of Acadia Healthcare stock opened at $28.72 on Tuesday. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20. The company has a fifty day simple moving average of $30.04 and a 200-day simple moving average of $25.69. The stock has a market cap of $2.67 billion, a price-to-earnings ratio of -2.31, a PEG ratio of 9.01 and a beta of 0.64. Acadia Healthcare Company, Inc. has a 12-month low of $11.43 and a 12-month high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The firm had revenue of $865.84 million for the quarter, compared to analyst estimates of $844.19 million. During the same period last year, the business earned $0.83 EPS. Acadia Healthcare’s revenue for the quarter was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, equities analysts forecast that Acadia Healthcare Company, Inc. will post 1.54 EPS for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.